Over the last four weeks there were 143 821 casesof COVID in the region. Please note that the actual number of cases is likely to be much more. For further information please go to Latest NSW COVID statistics.
Vaccination and previous COVID infection
The Australian Technical and Advisory Group on Immunisation (ATAGI) continues to advise that previous infection is not a contraindication to vaccination and vaccination can occur following recovery of acute illness from COVID-19.
People who have had COVID-19 can be vaccinated with a COVID-19 vaccine once they recover from the acute illness. There is no requirement to delay vaccination, however vaccination can be deferred for up to 4 months as past infection reduces the chance of reinfection for at least this amount of time. For more information see ATAGI expanded guidance on temporary medical exemptions for COVID-19 vaccine.
Novavax COVID-19 vaccine approved
Novavax COVID-19 vaccine has been approvedfor use in a primary course of vaccination in people aged 18 years and older. Novavax COVID-19 vaccine is a spike protein-based vaccine. Each 0.5mL dose contains 5 micrograms of the of SARS-CoV-2 spike protein and 50 micrograms of Matrix-M as an adjuvant.
ATAGI recommends that Novavax COVID-19 vaccine can be used for the primary course of COVID-19 vaccination in people aged 18 or older.
The recommended schedule for administration is 2 doses, a minimum of 3 weeks apart.
Novavax COVID-19 vaccine is not currently recommended for use as a booster vaccine.
CESPHN sent out an expression of interest to general practices wanting to deliver Novavax in the first window from mid to late February – this EOI closes on Wednesday 25 January. After this first delivery remaining practices who wish to administer Novavax will be progressively onboarded.
The Therapeutic Goods Administration has given provisional approval for two oral treatments for COVID-19; Lagevrio® (molnupiravir) and Paxlovid® (nirmatrelvir + ritonavir).
These treatments have been found to be effective in treating people with mild to moderate COVID-19 who have a high risk of progressing to severe disease, reducing admissions to hospital and ICU and potential death.
As supplies increase it is expected that these treatments will transition to the Pharmaceutical Benefits Scheme and be available on prescription.
Booster dose interval
Booster doses are available for those who completed their primary course of COVID-19 vaccination 3 or more months ago, using either the Comirnaty (Pfizer) or Spikevax (Moderna – half dose) vaccine for anyone aged 18 and older.
With the increasing numbers of COVID cases, low risk immunised patients (the majority of people) are being asked to self-manage at home. People who test positive to COVID (via PCR test or who report their positive RAT test) are receiving an SMS from NSW Health and asked to complete a brief survey that identifies those patients considered high risk.
High risk patients will be managed by the local health district virtual care units.
If your patient lives in South Eastern Sydney LHD use:
Distribution of pulse oximeters to patients identified as high risk is occurring via local health districts. CESPHN have access to a small supply. GPs with patients they believe require a pulse oximeter urgently are asked to email email@example.com with their name and address and we will arrange delivery of an oximeter.Practices actively seeing moderate risk COVID positive patients can also be sent up to five pulse oximeters.
Monday 31 January 7.00pm: RACGP and NSW Health COVID-19 update.
The following clinics are available for COVID-19 vaccinations for vulnerable groups in the region.
Lexo The Hub, Lexington Place, South Maroubra Fridays 10.00 am – 2.00 pm This clinic is for people living locally in social housing or experiencing or at risk of homelessness. No appointment needed.
Northcott Northcott Community Centre, Belvoir St, Surry Hills Mondays 10.00 am – 2.00 pm This clinic is for people living locally in social housing or experiencing or at risk of homelessness. No appointment needed.
CESPHN Vax at Home Service
Some people in our community may not be able to access a GP or vaccination hub to receive a COVID-19 vaccination. The CESPHN Vax at Home Service is ONLY for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster (their carers will also be able to be vaccinated).
Patient self-referrals will NOT be accepted. Patients should speak with their GP for referral to this program if appropriate. Referrals will be accepted from general practitioners and from Local Health Districts.
Referrals for people who live in the Sydney Local Health District and South Eastern Sydney Local Health District can be emailed to firstname.lastname@example.org.
Referrals should include:
Name of patient
Patient’s residential address and contact details
Name of usual GP
Contact details of any carers
Vaccine status e.g.: Ist dose, 2nd dose, booster
Which vaccine required
patient is housebound and not able to access a COVID vaccine elsewhere
you have obtained the patients consent to send this information to CESPHN.
This service is now operational and accepting referrals (please note there might be some delays as we respond to demand).
Additional PPE available
Pharmacists who are undertaking vaccinations may also receive a bundle of Personal Protective Equipment from our PHN that will support them for the next 4 weeks. Within this bundle each pharmacist is able to receive 90 N95 respirators and one set of goggles or a face shield. Following this initial bundle each pharmacist will be able to order N95 respirators until 31 March 2022. To order this PPE for your pharmacist click here.
General practice and community pharmacies
Personal Protective Equipment (PPE) packages including surgical and N95/P2 masks, are available for community pharmacies and those GPs who continue to see their patients within their practices. PPE guidelines can be found here. CESPHN will continue to distribute these supplies. To order PPE for your practice or pharmacy click here.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
Continuing Professional Development (CPD) annual requirements Below is a snapshot of the continuing professional development (CPD) requirements for doctors, these include annual requirements of: completion of a Professional Development Plan 50 hours CPD each year, split across a range of activities: 25 hours – reviewing performance and measuring outcomes (with five hours minimum…
CESPHN’s Annual Report 2022-23 is now live Central and Eastern Sydney PHN has released its Annual Report 2022-23. The Annual Report is a summary of the key achievements and highlights for the PHN over the financial year. It is split into Improving Care Integration, Improving Practice and Commissioning Services to…